Genome Editing: a Robust Technology for Human Stem Cells

Overview

Journal Cell Mol Life Sci

Publisher Springer

Specialty Biology

Date 2017 Apr 14

PMID 28405721

Citations 4

Authors

Arun Pandian Chandrasekaran

Minjung Song

Suresh Ramakrishna

Affiliations

Soon will be listed here.

Abstract

Human pluripotent stem cells comprise induced pluripotent and embryonic stem cells, which have tremendous potential for biological and therapeutic applications. The development of efficient technologies for the targeted genome alteration of stem cells in disease models is a prerequisite for utilizing stem cells to their full potential. Genome editing of stem cells is possible with the help of synthetic nucleases that facilitate site-specific modification of a gene of interest. Recent advances in genome editing techniques have improved the efficiency and speed of the development of stem cells for human disease models. Zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated system are powerful tools for editing DNA at specific loci. Here, we discuss recent technological advances in genome editing with site-specific nucleases in human stem cells.

Citing Articles

Revolutionizing medicine: recent developments and future prospects in stem-cell therapy.

Hussen B, Hussen B, Taheri M, Yashooa R, Abdullah G, Abdullah S Int J Surg. 2024; 110(12):8002-8024.

PMID: 39497543 PMC: 11634165. DOI: 10.1097/JS9.0000000000002109.

Gene Editing in Human Pluripotent Stem Cells: Recent Advances for Clinical Therapies.

Sisli H, Hayal T, Seckin S, Senkal S, Kiratli B, Sahin F Adv Exp Med Biol. 2019; 1237:17-28.

PMID: 31728915 DOI: 10.1007/5584_2019_439.

Highly Efficient Genome Engineering in and Using the CRISPR/Cas9 System.

Wang Y, Wang D, Wang X, Tao H, Feng E, Zhu L Front Microbiol. 2019; 10:1932.

PMID: 31551942 PMC: 6736576. DOI: 10.3389/fmicb.2019.01932.

Two decades of embryonic stem cells: a historical overview.

Eguizabal C, Aran B, Chuva de Sousa Lopes S, Geens M, Heindryckx B, Panula S Hum Reprod Open. 2019; 2019(1):hoy024.

PMID: 30895264 PMC: 6396646. DOI: 10.1093/hropen/hoy024.

References

Li T, Huang S, Zhao X, Wright D, Carpenter S, Spalding M . Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes. Nucleic Acids Res. 2011; 39(14):6315-25. PMC: 3152341. DOI: 10.1093/nar/gkr188. View

Xie F, Ye L, Chang J, Beyer A, Wang J, Muench M . Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac. Genome Res. 2014; 24(9):1526-33. PMC: 4158758. DOI: 10.1101/gr.173427.114. View

Yusa K, Rashid S, Strick-Marchand H, Varela I, Liu P, Paschon D . Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature. 2011; 478(7369):391-4. PMC: 3198846. DOI: 10.1038/nature10424. View

Wang J, Exline C, DeClercq J, Llewellyn G, Hayward S, Li P . Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors. Nat Biotechnol. 2015; 33(12):1256-1263. PMC: 4842001. DOI: 10.1038/nbt.3408. View

Swarts D, Mosterd C, van Passel M, Brouns S . CRISPR interference directs strand specific spacer acquisition. PLoS One. 2012; 7(4):e35888. PMC: 3338789. DOI: 10.1371/journal.pone.0035888. View

Gloor G, Nassif N, Preston C, Engels W . Targeted gene replacement in Drosophila via P element-induced gap repair. Science. 1991; 253(5024):1110-7. DOI: 10.1126/science.1653452. View

Boettcher M, McManus M . Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR. Mol Cell. 2015; 58(4):575-85. PMC: 4441801. DOI: 10.1016/j.molcel.2015.04.028. View

Costa M, Dottori M, Sourris K, Jamshidi P, Hatzistavrou T, Davis R . A method for genetic modification of human embryonic stem cells using electroporation. Nat Protoc. 2007; 2(4):792-6. DOI: 10.1038/nprot.2007.105. View

van der Oost J, Jore M, Westra E, Lundgren M, Brouns S . CRISPR-based adaptive and heritable immunity in prokaryotes. Trends Biochem Sci. 2009; 34(8):401-7. DOI: 10.1016/j.tibs.2009.05.002. View

10.

Park I, Zhao R, West J, Yabuuchi A, Huo H, Ince T . Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2007; 451(7175):141-6. DOI: 10.1038/nature06534. View

11.

Smih F, Rouet P, Romanienko P, Jasin M . Double-strand breaks at the target locus stimulate gene targeting in embryonic stem cells. Nucleic Acids Res. 1995; 23(24):5012-9. PMC: 307507. DOI: 10.1093/nar/23.24.5012. View

12.

Maeder M, Thibodeau-Beganny S, Sander J, Voytas D, Joung J . Oligomerized pool engineering (OPEN): an 'open-source' protocol for making customized zinc-finger arrays. Nat Protoc. 2009; 4(10):1471-501. PMC: 2858690. DOI: 10.1038/nprot.2009.98. View

13.

Urnov F, Miller J, Lee Y, Beausejour C, Rock J, Augustus S . Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature. 2005; 435(7042):646-51. DOI: 10.1038/nature03556. View

14.

Mahfouz M, Li L, Shamimuzzaman M, Wibowo A, Fang X, Zhu J . De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks. Proc Natl Acad Sci U S A. 2011; 108(6):2623-8. PMC: 3038751. DOI: 10.1073/pnas.1019533108. View

15.

Soldner F, Laganiere J, Cheng A, Hockemeyer D, Gao Q, Alagappan R . Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell. 2011; 146(2):318-31. PMC: 3155290. DOI: 10.1016/j.cell.2011.06.019. View

16.

Tebas P, Stein D, Tang W, Frank I, Wang S, Lee G . Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med. 2014; 370(10):901-10. PMC: 4084652. DOI: 10.1056/NEJMoa1300662. View

17.

Ran F, Hsu P, Lin C, Gootenberg J, Konermann S, Trevino A . Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell. 2013; 154(6):1380-9. PMC: 3856256. DOI: 10.1016/j.cell.2013.08.021. View

18.

Deng D, Yin P, Yan C, Pan X, Gong X, Qi S . Recognition of methylated DNA by TAL effectors. Cell Res. 2012; 22(10):1502-4. PMC: 3463267. DOI: 10.1038/cr.2012.127. View

19.

Osborn M, Starker C, McElroy A, Webber B, Riddle M, Xia L . TALEN-based gene correction for epidermolysis bullosa. Mol Ther. 2013; 21(6):1151-9. PMC: 3677309. DOI: 10.1038/mt.2013.56. View

20.

Ruby K, Zheng B . Gene targeting in a HUES line of human embryonic stem cells via electroporation. Stem Cells. 2009; 27(7):1496-506. DOI: 10.1002/stem.73. View